Transcatheter Mitral Valve Replacement with Dedicated Devices
By: Joe Aoun, Michael J. Reardon and Sachin S. Goel
References
- Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014 Jan 21;63(2):185–6. doi: 10.1016/j.jacc.2013.08.723
- Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007 Jun;28(11):1358–65. doi: 10.1093/eurheartj/ehm001
- Grinberg D, Pozzi M, Bernard C, Obadia JF. A tensed Tendyne. Eur J Cardiothorac Surg. 2020 Sep 1;58(3):651–653. doi: 10.1093/ejcts/ezaa109
- Aktuerk D, Jansz P, Shaw M, Muller DWM. Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart. Catheter Cardiovasc Interv. 2020 Jan;95(1):E37–E39. doi: 10.1002/ccd.28210
- Badhwar V, Sorajja P, Duncan A, et al. Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation. EuroIntervention. 2019 Dec 20;15(12):e1065–e1071. doi: 10.4244/EIJ-D-19-00333
- Muller DWM, Sorajja P, Duncan A, et al. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation. J Am Coll Cardiol. 2021 Nov 9;78(19):1847–1859. doi: 10.1016/j.jacc.2021.08.060
- Muller DWM, Farivar RS, Jansz P, et al. Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial. J Am Coll Cardiol. 2017 Jan 31;69(4):381–391. doi: 10.1016/j.jacc.2016.10.068
- Sorajja P, Moat N, Badhwar V, et al. Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. J Am Coll Cardiol. 2019 Mar 26;73(11):1250–1260. doi: 10.1016/j.jacc.2018.12.066
- ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine;
c2023. Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) ; 2023 Mar 23 [cited 2023 Apr 15]. Available from:https://clinicaltrials.gov/ct2/show/NCT03433274 - McCarthy PM, Kislitsina ON, Malaisrie SC, Davidson CJ. Transcatheter Mitral Valve Replacement with Intrepid. Interv Cardiol Clin. 2019 Jul;8(3):287–294. doi: 10.1016/j.iccl.2019.02.002
- Bapat V, Rajagopal V, Meduri C, et al. Early Experience With New Transcatheter Mitral Valve Replacement. J Am Coll Cardiol. 2018 Jan 2;71(1):12–21. doi: 10.1016/j.jacc.2017.10.061
- Zahr F, Song HK, Chadderdon SM, et al. 30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results. JACC Cardiovasc Interv. 2022 Jan 10;15(1):80–89. doi: 10.1016/j.jcin.2021.10.018
- ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine;
c2023. APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP) ; 2018 Nov [cited 2023 Apr 25]. Available from:https://clinicaltrials.gov/ct2/show/NCT01960348 - Nunes Ferreira-Neto A, Dagenais F, Bernier M, Dumont E, Freitas-Ferraz AB, Rodés-Cabau J. Transcatheter Mitral Valve Replacement With a New Supra-Annular Valve: First-in-Human Experience With the AltaValve System. JACC Cardiovasc Interv. 2019 Jan 28;12(2):208–209. doi: 10.1016/j.jcin.2018.10.056
- Goel SS, Zuck V, Christy J, et al. Transcatheter Mitral Valve Therapy With Novel Supra-Annular AltaValve: First Experience in the United States. JACC Case Rep. 2019 Dec 18;1(5):761–764. doi: 10.1016/j.jaccas.2019.10.034
- ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine;
c2023. Early Feasibility Study of the Neovasc TiaraTM Mitral Valve System (TIARA-I) ; 2022 Jan 18 [cited 2023 Apr 25]. Available from:https://clinicaltrials.gov/ct2/show/results/NCT02276547 - Webb JG, Murdoch DJ, Boone RH, et al. Percutaneous Transcatheter Mitral Valve Replacement: First-in-Human Experience With a New Transseptal System. J Am Coll Cardiol. 2019 Mar 26;73(11):1239–1246. doi: 10.1016/j.jacc.2018.12.065
- Makkar R, O’Neill W, Whisenant B, et al. Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System. J Am Coll Cardiol. 2019 Sep 1;74(13):B8.
- Webb J, Hensey M, Fam N, et al. Transcatheter Mitral Valve Replacement With the Transseptal EVOQUE System. JACC Cardiovasc Interv. 2020 Oct 26;13(20):2418–2426. doi: 10.1016/j.jcin.2020.06.040
- ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine;
c2023. Edwards EVOQUE Eos MISCEND Study ; 2023 Jan 23 [cited 2023 Apr 25]. Available from:https://clinicaltrials.gov/ct2/show/NCT02718001 - Alperi A, Dagenais F, Del Val D, et al. Early Experience With a Novel Transfemoral Mitral Valve Implantation System in Complex Degenerative Mitral Regurgitation. JACC Cardiovasc Interv. 2020 Oct 26;13(20):2427–2437. doi: 10.1016/j.jcin.2020.08.006
- Modine T, Vahl TP, Khalique OK, et al. First-in-Human Implant of the Cephea Transseptal Mitral Valve Replacement System. Circ Cardiovasc Interv. 2019 Sep;12(9):
e008003 . doi: 10.1161/CIRCINTERVENTIONS.119.008003 - Rottbauer W, Schneider L, Nickenig G, et al. TCT-191 HighLife Trans-Septal Mitral Valve Replacement (TSMVR) System; Early and Long Term Clinical and Hemodynamic Outcomes of the First 30 Consecutive Cases; The HighLife Feasibility Studies in Europe, Australia, and the US. J Am Coll Cardiol. 2021 Nov 9;78(19_Supplement_S):B78–9.
- ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine;
c2023. HighLifeTM Transcatheter Mitral Valve Replacement System Study ; 2022 Sep 15 [cited 2023 Apr 25]. Available from:https://clinicaltrials.gov/ct2/show/NCT02974881 - Innovalvemed.com [Internet]. Ramat Gan, Israel;
c2023. Our Technology ; 2023 [cited 2023 Apr 25]. Available from:https://www.innovalvemed.com/technology/ - ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine;
c2023. TVMR With the Innovalve System Trial - Early Feasibility Study (TWIST-ESF) ; 2022 Dec 23 [cited 2023 Apr 25]. Available from:https://clinicaltrials.gov/ct2/show/NCT04919980
DOI: https://doi.org/10.14797/mdcvj.1231 | Journal eISSN: 1947-6108
Language: English
Page range: 50 - 56
Submitted on: Mar 19, 2023
Accepted on: Apr 26, 2023
Published on: May 16, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2023 Joe Aoun, Michael J. Reardon, Sachin S. Goel, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.